OMRON Healthcare Surpasses 50 Million Nebulizer Sales, Revolutionizing Respiratory Care

OMRON HEALTHCARE Co., Ltd. has announced that its cumulative sales of nebulizers have exceeded 50 million units. This achievement highlights the company's ongoing mission to improve global respiratory health with user-friendly, home-based medical devices. These nebulizers are crucial for treating conditions such as asthma and COPD worldwide.

KYOTO, Japan, Nov. 28, 2025 /Kyodo JBN/ -- Nearly 50 years after the release of its inaugural nebulizer, OMRON HEALTHCARE Co., Ltd., has hit a significant milestone by surpassing the sale of 50 million units globally. This achievement underscores the company's dedication to advancing respiratory health management.

Respiratory diseases are increasingly affecting the global population, especially in emerging economies. The World Health Organization reports about 339 million asthma sufferers, with 3.5 million annual COPD-related deaths. Nebulizers are vital in mitigating respiratory issues by converting liquid medications into inhalable mists.

Since 1978, OMRON Healthcare has championed the development of compact, home-use devices, facilitating medical-grade respiratory treatments outside clinical settings. The evolution from ultrasonic to portable mesh-type technologies illustrates significant innovations catering to millions affected by respiratory ailments globally.

(With inputs from agencies.)